| 摘要 |
<p>The present invention relates to compounds according to the general formula (I) which bind to the nuclear receptor, NR1H4, and act as agonists, antagonists or mixed agonists / antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds.</p> |
